Harrow Health Analyst Ratings
Harrow Health Analyst Ratings
While ratings are subjective and will change, the latest Harrow Health (HROW) rating was a maintained with a price target of $42.00 to $45.00. The current price Harrow Health (HROW) is trading at is $21.74, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/20/2023 | 106.99% | B. Riley Securities | $42 → $45 | Maintains | Buy |
| 04/17/2023 | 70.19% | Lake Street | $24 → $37 | Maintains | Buy |
| 09/08/2022 | -21.8% | B. Riley Securities | → $17 | Reinstates | → Buy |
| 05/20/2022 | -8% | B. Riley Securities | $17 → $20 | Maintains | Buy |
| 07/02/2021 | -34.45% | Ladenburg Thalmann | → $14.25 | Initiates Coverage On | → Buy |
| 04/07/2020 | -54% | B. Riley Securities | $12 → $10 | Maintains | Buy |
| 03/16/2020 | -44.8% | B. Riley Securities | $12.75 → $12 | Maintains | Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 07/20/2023 | 106.99% | B. 萊利證券 | 42 美元 → 45 美元 | 維護 | 購買 |
| 04/17/2023 | 70.19% | 湖街 | 24 美元 → 37 美元 | 維護 | 購買 |
| 09/08/2022 | -21.8% | B. 萊利證券 | → 17 美元 | 恢復 | → 購買 |
| 05/20/2022 | -8% | B. 萊利證券 | 17 美元 → 20 美元 | 維護 | 購買 |
| 07/02/2021 | -34.45% | 拉登堡塔爾曼 | → 14.25 美元 | 啓動覆蓋開啓 | → 購買 |
| 2020 年 7 月 4 日 | -54% | B. 萊利證券 | 12 美元 → 10 美元 | 維護 | 購買 |
| 03/16/2020 | -44.8% | B. 萊利證券 | 12.75 美元 → 12 美元 | 維護 | 購買 |
What is the target price for Harrow Health (HROW)?
Harrow Health（HROW）的目標價格是多少？
The latest price target for Harrow Health (NASDAQ: HROW) was reported by B. Riley Securities on July 20, 2023. The analyst firm set a price target for $45.00 expecting HROW to rise to within 12 months (a possible 106.99% upside). 3 analyst firms have reported ratings in the last year.
B. Riley Securities於2023年7月20日公佈了哈羅健康（納斯達克股票代碼：HROW）的最新目標股價。這家分析公司將目標股價定爲45.00美元，預計HROW將在12個月內升至106.99％（可能上漲106.99％）。去年有3家分析公司公佈了評級。
What is the most recent analyst rating for Harrow Health (HROW)?
分析師對哈羅健康（HROW）的最新評級是多少？
The latest analyst rating for Harrow Health (NASDAQ: HROW) was provided by B. Riley Securities, and Harrow Health maintained their buy rating.
哈羅健康（納斯達克股票代碼：HROW）的最新分析師評級由B. Riley Securities提供，哈羅健康維持買入評級。
When is the next analyst rating going to be posted or updated for Harrow Health (HROW)?
Harrow Health（HROW）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Harrow Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Harrow Health was filed on July 20, 2023 so you should expect the next rating to be made available sometime around July 20, 2024.
分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與Harrow Health的高管和客戶交談以及聽取財報電話會議）後得出股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Harrow Health 的最後一次評級是在2023年7月20日提交的，因此你應該預計下一個評級將在2024年7月20日左右公佈。
Is the Analyst Rating Harrow Health (HROW) correct?
分析師對 Harrow Health (HROW) 的評級正確嗎？
While ratings are subjective and will change, the latest Harrow Health (HROW) rating was a maintained with a price target of $42.00 to $45.00. The current price Harrow Health (HROW) is trading at is $21.74, which is out of the analyst's predicted range.
儘管評級是主觀的，將會發生變化，但最新的Harrow Health（HROW）評級維持不變，目標股價爲42.00美元至45.00美元。Harrow Health（HROW）目前的交易價格爲21.74美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。